We are live on ! Find out more
WMSA

Weiss Multi-Strategy Advisers Portfolio holdings

AUM $4.16B
1-Year Est. Return 30.77%
This Fund
S&P 500
This Quarter Est. Return
-2.79%
1 Year Est. Return
+30.77%
3 Year Est. Return
+78.91%
5 Year Est. Return
+263.81%
10 Year Est. Return
+424.97%
AUM
$4.09B
AUM Growth
-$502M
Cap. Flow
-$407M
Cap. Flow %
-9.94%
Top 10 Hldgs %
30.55%
Holding
883
New
176
Increased
142
Reduced
142
Closed
370

Top Buys

Rank Stock Value
1
EGN
Energen
EGN
+$29.1M
2
C icon
Citigroup
C
+$28.9M
3
CCEP icon
Coca-Cola Europacific Partners
CCEP
+$27.4M
4
PKY
Parkway, Inc.
PKY
+$24.6M
5
NRG icon
NRG Energy
NRG
+$23.4M

Sector Composition

Rank Sector Weight
1 Financials 11.83%
2 Energy 9.56%
3 Real Estate 7.25%
4 Consumer Staples 5.69%
5 Healthcare 5.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SQNM
476
DELISTED
SEQUENOM INC NEW
SQNM
$297K 0.01%
100,000
RIGL icon
477
Rigel Pharmaceuticals
RIGL
$702M
$291K 0.01%
15,000
KTWO
478
DELISTED
K2M Group Holdings, Inc
KTWO
$289K 0.01%
20,000
+8,000
+67% +$120K
KITE
479
DELISTED
Kite Pharma, Inc.
KITE
$285K 0.01%
+10,000
New +$247K
OPCH icon
480
Option Care Health
OPCH
$3.44B
$276K 0.01%
+10,000
New +$310K
SDRL
481
CALL
DELISTED
Seadrill Limited Common Stock
SDRL
$268K 0.01%
+37
New +$350K
STAA icon
482
STAAR Surgical
STAA
$1.15B
$266K 0.01%
25,000
+5,000
+25% +$59.4K
RAD
483
DELISTED
Rite Aid Corporation
RAD
$266K 0.01%
+2,750
New +$355K
APEN
484
DELISTED
Apollo Endosurgery, Inc.
APEN
$264K 0.01%
974
ACHN
485
DELISTED
Achillion Pharmaceuticals
ACHN
$250K 0.01%
25,000
ARAV
486
DELISTED
Aravive, Inc. Common Stock
ARAV
$247K 0.01%
2,167
VXX
487
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
$234K 0.01%
468
VOLC
488
CALL
DELISTED
VOLCANO CORPORATION COM STK
VOLC
$213K 0.01%
+20,000
New +$277K
ABUS icon
489
PUT
Arbutus Biopharma
ABUS
$881M
$211K 0.01%
+10,000
New +$163K
SRPT icon
490
Sarepta Therapeutics
SRPT
$1.71B
$211K 0.01%
10,000
STFC
491
DELISTED
State Auto Financial Corp
STFC
$205K 0.01%
10,000
-25,872
-72% -$562K
GSL icon
492
Global Ship Lease
GSL
$1.56B
$198K ﹤0.01%
6,184
-18,370
-75% -$574K
RVNC
493
DELISTED
Revance Therapeutics, Inc.
RVNC
$193K ﹤0.01%
10,000
VVUS
494
DELISTED
Vivus Inc
VVUS
$193K ﹤0.01%
5,000
RPTP
495
CALL
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
$192K ﹤0.01%
20,000
+1,100
+6% +$11.2K
TNK icon
496
CALL
Teekay Tankers
TNK
$2.62B
$183K ﹤0.01%
6,125
PCOM
497
DELISTED
Points.com Inc. Common Shares
PCOM
$174K ﹤0.01%
+10,000
New +$194K
FLEX icon
498
Flex
FLEX
$40.7B
$155K ﹤0.01%
+19,905
New +$163K
ARCT icon
499
Arcturus Therapeutics
ARCT
$161M
$154K ﹤0.01%
+1,429
New +$186K
GERN icon
500
Geron
GERN
$962M
$150K ﹤0.01%
75,000
-4,350
-5% -$10.7K

Similar funds

Weiss Multi-Strategy Advisers's Q3 2014 Portfolio in Review

As of Q3 2014, Weiss Multi-Strategy Advisers held 883 positions worth $4.09B, down 11% from $4.6B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Weiss Multi-Strategy Advisers withdrew a net $407M in Q3 2014, closing 370 positions and reducing 142 holdings. Its most notable exit was Lamar Advertising Co, an estimated $37.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 9.4% a quarter earlier, followed by Energy and Real Estate.

Against the trend, Weiss Multi-Strategy Advisers opened a new position in Energen worth $26.3M.

  • Weiss Multi-Strategy Advisers's largest Q3 2014 buy was Energen: 363,900 shares worth $26.3M.
  • Weiss Multi-Strategy Advisers added most to Coca-Cola in Q3 2014, an estimated $22.4M increase.
  • Weiss Multi-Strategy Advisers's biggest Q3 2014 reduction was Fifth Third Bancorp, cutting an estimated $30.8M.
  • Weiss Multi-Strategy Advisers fully exited Lamar Advertising Co in Q3 2014, selling an estimated $37.1M.
  • Weiss Multi-Strategy Advisers's ten largest holdings make up 31% of its $4.09B portfolio in Q3 2014.
  • Weiss Multi-Strategy Advisers opened 176 new positions and closed 370 in Q3 2014.
  • Weiss Multi-Strategy Advisers's portfolio value fell 11% quarter-over-quarter to $4.09B.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2014, filed 14 Nov 2014.